The following studies are now seeking participants. AstraZeneca/TRITON (D419ML00003) - Maurice Willis, M.D. The purpose of the study is to assess the efficacy of durvalumab plus tremelimumab in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback